Peer Review History
| Original SubmissionDecember 21, 2020 |
|---|
|
PONE-D-20-40095 Production and сharacterization of the exopolysaccharide from novel strain Paenibacillus polymyxa 2020 PLOS ONE Dear Dr. Formenkov, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by March 05, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Dharam Singh Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3.We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Please upload a copy of Figure 14, to which you refer in your text on page 22. If the figure is no longer to be included as part of the submission please remove all reference to it within the text. 5.Thank you for stating the following in the Competing Interests section: "A.F, S.V. and R.J.R. work for New England Biolabs, company that sells research reagents, including restriction, glyco enzymes and DNA methyltransferases, to the scientific community. " We note that one or more of the authors are employed by a commercial company: New England Biolabs Inc., a) Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. b) Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 6.Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author. Introduction section: - https://www.sciencedirect.com/science/article/abs/pii/S0141813018332847?via%3Dihub Results, Discussion, and Conclusion sections: - https://microbialcellfactories.biomedcentral.com/articles/10.1186/s12934-016-0603-7 - https://mra.asm.org/content/8/32/e00657-19 - https://pubmed.ncbi.nlm.nih.gov/31879785/ - https://www.sciencedirect.com/science/article/abs/pii/S0141813018332847?via%3Dihub - https://link.springer.com/article/10.1007/BF01569633 - https://www.sciencedirect.com/science/article/abs/pii/S0141813016308777?via%3Dihub - https://www.sciencedirect.com/science/article/abs/pii/S014486171630114X?via%3Dihub - https://www.frontiersin.org/articles/10.3389/fbioe.2020.603407/full We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications. Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work. We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study reports about isolation of Paenibacillus polymyxa 2020 from wasp honeycombs capable of producing levan. Whole genome sequencing and methylome analysis of P. polymyxa 2020 were performed and bioinformatic analysis identified putative levan synthetic operon. sacC and sacB genes were further cloned and their products identified. To reduce the production cost inexpensive substrate molasses was investigated for EPS production. Manuscript needs following changes to improve it further. Comments: 1. Remove word novel from title as many Paenibacillus strains already isolated and reported for different applications. 2. In introduction part add information related to different exopolysaccharides, microorganisms, and their applications. Also add information related to market potential of levan and other EPS. 3. Line 138: Why author decided to use 10% v/v inoculum? Why author didn’t try to optimize various culture conditions for optimum growth and EPS production, as this was a new isolate, and these parameters may help to increase production. 4. What are other components present in EPS? As EPS is composed of carbohydrates, proteins, organic acids etc. 5. Line 339: P. polymyxa 2020 showed a high content of EPS in comparison to other strain at almost same concentration of sucrose. Compare in terms of culture conditions also (pH and T) used in this study and other study to provide better information to readers. 6. Provide figure number to all the figures. 7. Remove grid lines from the figures. 8. Line 99: C/N and pH plays important role in EPS production, while in this study no such experiment included. Need to perform experiment and include results. Reviewer #2: The paper is interesting in describing a new strain with relevant biosynthetic pathways to exopoysaccharide production, and the ability to achieve high titer of EPS. The authors run a wide array of characterization experiments, from a biomolecular and biological side to a more chemical-structure analyses. However the manuscript fails to correctly describe in detail the experimental part. I think there is a need to improve the methodologies section few examples are following: Improvement of fermentation descriptions, give detains on growth. explain how they can purify and isolate EPS with such a simple 2 step process (comparison to other EPS, contamination of polysaccharides from teh media...etc.) Clarify why they use high temperature drying improve SEM analyses description compared their limitation in NMR to eventually previously reported spectroscopic analyses of heteropolysaccarides like hyaluronic acid, or other GAGs.; Explain the meaning of the cytotoxicity study with respect to a proposed application; e) describe the specific interest in the molecular determinant of the biosynthetic pathways, since they report already a very high production (and productivity) when compared to other microbial polysaccharides. Minor points are also highlighted below:The shake flasks growth, although a simple and routine approach should be better described here (biomass density achieved, growth curve, or any othe information like change in pH during growth. If the process is a fully aerobic one it seems that the inoculums of 100 mL medium in a 250 mL flask is not ensuring a sound gas distribution, so is limiting oxygen transfer, this especially in relation to the increase n velocity during growth. In Figure 2 the production of levan is presented without any information on the biomass growth. Since the authors are using a very high sugar content (either a disaccharide or a complex mixtures ..also containing oligo saccharides) the osmotic pressure will be different in the various condition and thus I will expect a difference in growth rate and then of Levan production. The reference at time zero (for zero amount of levan ) was quantified on the medium of this was an assumption of the authors? Please specify. The downstream procedure described is very simple, I argue it is very difficult to separate pure EPS only using precipitation and dialysis , did the author apply th e same procedure to the fermentation broth to analyse similar residues directly coming from the complex components (e.g. yeast extract or other) . Fig 10. SEM images of EPS of P. polymyxa 2020 at a various magnification- please improve description in the legend SEM micrograph should be better explained in the text (how the films were obtained, and with procedeure before metalization. It is not clear why a porosity should be found if not for very low molecular weight components (like salts) that may leave the film if washed . The authors should clarify this point0 Figure 12 is very confusing, and low quality I appreciated the effort of the research group to address all together key aspects of production and purification of microbial polysaccharides, but such an extensive overview shoudl not limit the relevant information to sustain the quality of the research and the reproducibility of the results. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Shashi Kant Bhatia Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-40095R1 Production and сharacterization of the exopolysaccharide from strain Paenibacillus polymyxa 2020 PLOS ONE Dear Dr. Formenkov, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see below for my specific comments. Please submit your revised manuscript by June 10, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Dharam Singh Academic Editor PLOS ONE Additional Editor Comments (if provided): Dear Authors, Although, revision is much improved but still I feel that there are concerns that need to be corrected before making final decision. Please see the following concerns. 1. Writing part is poorly managed through the manuscript. Basically, each paragraph should be arranged as a unit that should be in coherent with another para. But, if you see text has been arranged as small small (5-6 lines) distributed text. See lines 65-75. They can be come under single para. Similar is the problem throughout the introduction, materials and methods section, results and discussion. To refer few of them as lines 353-394, 414-424, 478-491 etc.. 2. Supplementary S6: correct the concentration from 0,31 to 0.31 mg/ml. Similarly for other values too. 3. S7 Fig. is not labeled. Position of Protein marker is not defined. 4. What is the PI of cloned proteins? May be the negative charge of proteins have led to slow migration in the gel in S7Fig. 5. Besides, there are still several mistakes through the manuscript that need to be corrected. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Author has revised the manuscript according to the reviewers comment. Manuscript is recommended for publication in its present form. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Shashi Kant Bhatia [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Production and сharacterization of the exopolysaccharide from strain Paenibacillus polymyxa 2020 PONE-D-20-40095R2 Dear Dr. Formenkov, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Dharam Singh Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-40095R2 Production and сharacterization of the exopolysaccharide from strain Paenibacillus polymyxa 2020 Dear Dr. Fomenkov: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Dharam Singh Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .